Connor, Clark & Lunn Investment Management (CC&L)’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.18M | Buy |
448,515
+84,286
| +23% | +$1.35M | 0.03% | 488 |
|
|
2025
Q1 | $6.22M | Buy |
364,229
+128,345
| +54% | +$2.19M | 0.03% | 445 |
|
|
2024
Q4 | $5.84M | Buy |
235,884
+54,085
| +30% | +$1.34M | 0.03% | 446 |
|
|
2024
Q3 | $5.18M | Sell |
181,799
-56,789
| -24% | -$1.62M | 0.03% | 423 |
|
|
2024
Q2 | $6.3M | Buy |
238,588
+94,203
| +65% | +$2.49M | 0.03% | 375 |
|
|
2024
Q1 | $4.67M | Sell |
144,385
-5,855
| -4% | -$189K | 0.02% | 447 |
|
|
2023
Q4 | $6.33M | Sell |
150,240
-96,942
| -39% | -$4.08M | 0.03% | 359 |
|
|
2023
Q3 | $9.49M | Buy |
247,182
+99,378
| +67% | +$3.82M | 0.05% | 256 |
|
|
2023
Q2 | $2.8M | Buy |
147,804
+85,421
| +137% | +$1.62M | 0.01% | 521 |
|
|
2023
Q1 | $968K | Buy |
62,383
+36,164
| +138% | +$561K | 0.01% | 723 |
|
|
2022
Q4 | $465K | Buy |
26,219
+7,867
| +43% | +$140K | ﹤0.01% | 878 |
|
|
2022
Q3 | $102K | Buy |
+18,352
| New | +$102K | ﹤0.01% | 1040 |
|
|
2022
Q2 | – | Sell |
-44,668
| Closed | -$246K | – | 1114 |
|
|
2022
Q1 | $246K | Sell |
44,668
-110,373
| -71% | -$608K | ﹤0.01% | 912 |
|
|
2021
Q4 | $1.32M | Buy |
155,041
+76,990
| +99% | +$656K | 0.01% | 627 |
|
|
2021
Q3 | $678K | Buy |
+78,051
| New | +$678K | ﹤0.01% | 710 |
|